Synthesis and characterization of chitosan oligosaccharide-capped gold nanoparticles as an effective antibiofilm drug against the Pseudomonas aeruginosa PAO1

• Published in: Microbial pathogenesis Vol. 135; p. 103623
• Main Authors: Khan, Fazlurrahman, Lee, Jang-Won, Manivasagan, Panchanathan, Pham, Dung Thuy Nguyen, Oh, Junghwan, Kim, Young-Mog
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.10.2019
• Subjects: Anti-Bacterial Agents - pharmacology; Antibiofilm; Biofilms - drug effects; Chitosan - chemistry; Chitosan oligosaccharide; Gold - chemistry; Kinetics; Metal Nanoparticles - chemistry; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Nanoparticles; Oligosaccharides - pharmacology; P. aeruginosa; Particle Size; Pathogen; Pseudomonas aeruginosa - drug effects; Pseudomonas aeruginosa - growth & development; Spectroscopy, Fourier Transform Infrared; Virulence; Virulence Factors; X-Ray Diffraction; Nanoparticles; Antibiofilm; Chitosan oligosaccharide; Pathogen; Virulence; P. aeruginosa
• ISSN: 0882-4010; 1096-1208
• DOI: 10.1016/j.micpath.2019.103623

The infection caused by Pseudomonas aeruginosa is a serious concern in human health. The bacterium is an opportunistic pathogen which has been reported to cause nosocomial and chronic infections through biofilm formation and synthesis of several toxins and virulence factors. Furthermore, the formation of biofilm by P. aeruginosa is known as one of the resistance mechanisms against conventional antibiotics. Natural compounds from marine resources have become one of the simple, cost-effective, biocompatible and non-toxicity for treating P. aeruginosa biofilm-related infections. Furthermore, hybrid formulation with nanomaterials such as nanoparticles becomes an effective alternative strategy to minimize the drug toxicity problem and cytotoxicity properties. For this reason, the present study has employed chitosan oligosaccharide for the synthesis of chitosan oligosaccharide-capped gold nanoparticles (COS-AuNPs). The synthesized COS-AuNPs were then characterized by using UV–Visible spectroscopy, Dynamic light scattering (DLS), Fourier transform infrared spectroscopy (FTIR), Field emission transmission electron microscopy (FE-TEM), and Energy dispersive X-ray diffraction (EDX). The synthesized COS-AuNPs were applied for inhibiting P. aeruginosa biofilm formation. Results have shown that COS-AuNPs exhibited inhibition to biofilm as well as eradication to pre-existing mature biofilm. Simultaneously, COS-AuNPs were also able to reduce bacterial hemolysis and different virulence factors produced by P. aeruginosa. Overall, the present study concluded that the hybrid nanoformulation such as COS-AuNPs could act as a potential agent to exhibit inhibitory properties against the P. aeruginosa pathogenesis arisen from biofilm formation. •COS-AuNP was synthesized and subjected to characterization by FTIR, EDX, XRD and FE-TEM.•COS-AuNP inhibited P. aeruginosa biofilm formation and eradicated the mature biofilm.•COS-AuNP inhibited hemolytic activity, virulence factors production and motilities.